Hospital

Patients with C. difficile who received clonal bacteria populations via biotherapeutic injection were able to repopulate their microbiota with commensal bacteria.

Individualized treatments like cell and gene therapies are poised to scale rapidly over the next decade.

Josh Marsh, vice president and general manager of Sonexus Access and Patient Support at Cardinal Health, discussed how patient assistance programs are leveraging technology.

Tackling racial disparities among health care providers can help improve disparities faced by patients.

Closely monitored, decentralized trials have also been shown to improve electronic patient reported outcomes to 92% compliance, according to ObvioHealth.

A daily low-dose form of vitamin D3 was more effective on cancer mortality than intake of a monthly high-dose form, especially for adults aged 70 years and older.

A novel collaboration between the University of Pennsylvania and US Anesthesia Partners is working to drive evidence-based change in benzodiazepine use.

Study of cell exhaustion in immunotherapy-resistant tumors could significantly improve the benefits of cancer immunotherapy for patients with treatment resistant types of cancer.

Commonly, essential yet routine and time-consuming tasks, such as answering phone calls, scheduling appointments, or other administrative work, prevent health care workers from focusing on more value-added and enjoyable job functions.

The extra surveillance by a specialty pharmacy teams allows for faster initiation of therapy, earlier recognition of adverse effects, and promotes patient safety.

US Preventive Services Task Force also called for more research into how to address screening and treatment disparities faced by racial and ethnic minorities.

Importantly, Sullivan said data show that adverse events in the home infusion environment are no higher than in any other setting.

During a fireside chat, USP CEO Ronald T. Piervincenzi, PhD, and the Honorable Dr. Oh Yu-Kyoung, Minister of MFDS, Republic of Korea, discuss interruptions to the medical supply chain and the interventions used.

As patents expire, the development of biosimilars may increase, opening up new opportunities to compare efficacies of these drugs.

Naiffer Romero, MSc, MPH, discusses his work at U.S. Pharmacopeia to regulate nitrosamine impurities and ensure medication quality.

Dapagliflozin was established as the first SGLT2 inhibitor that demonstrated a mortality benefit for cardiovascular death from heart failure.

Shweta S. Namjoshi, MD, MPH, CNSC, discusses the role of the pharmacists in gastrointestinal care and the differences in care for pediatrics and adults.

Evidence suggest better outcomes results when a program is responsive to the significant needs of this population.

Findings may offer insight into new strategies to tackle skin cancer in patients already treated with a prior line of therapy.

Lack of awareness, or anosognosia, may be present up to 2 to 3 years before an Alzheimer dementia diagnosis is made.

Having scheduled check-ins for an ongoing trial arguably helps patients feel more informed and in charge of their health.

Kimlin Tam Ashing, PhD, discusses her research assessing effective interventions in ethnic minority communities to increase colorectal cancer screenings.

Following 2 opposing decisions from judges in Texas and Washington State, Lanton said the issue is back in the Supreme Court.

Pharmacists, in particular, must be cautious and deliberate in using ChatGPT to ensure that its benefits are fully realized while minimizing risk and misinformation.

There was a decreasing trend for new-onset atrial fibrillation incidence with higher cumulative doses of dexmedetomidine.

There are common symptoms experienced in the workplace that may be linked to hormones instead of stress.

Alpelisib plus the antioxidant N-acetylcysteine sensitizes NF1 knockout cells to PI3Kα inhibition and reverts their glycolytic phenotype in patients with advanced forms of breast cancer.

Comorbidities and cognitive impairment worsen non-adherence to anti-seizure medications in older adults.

The study will be conducted in Brazil, where PrEP use for HIV continues to be lower than desired.

The novel antibody-drug conjugate is the first to demonstrate overall survival benefits in patients who were already treated with therapy.